" class="no-js "lang="en-US"> Evidence Partners - Medtech Alert
Wednesday, March 22, 2023

Breaking News

Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Dupixent® (dupilumab) Approved by European Commission as First and Only Targeted Medicine for Children as Young as Six Months Old with Severe Atopic Dermatitis Gamida Cell Announces Changes to Board of Directors Newron Reports Topline Results From All Patients in Study Evaluating Evenamide as Add-on Therapy for Treatment-Resistant Schizophrenia Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer TFS HealthScience Expands Operations into Israel, With Focus on Continuous, Rapid International Expansion
Evidence Partners | Pharmtech Focus

Evidence Partners

About Evidence Partners

Evidence Partners
DistillerSR is the market leader in AI-enabled literature review automation software. More than 300 of the world’s leading research organizations, including 60% of the largest pharmaceutical and medical device companies, contract research organizations, governments, NGOs, and academic institutions trust DistillerSR to securely produce transparent, audit-ready, and regulatory compliant literature reviews faster and more accurately than any other method. As a result, healthcare researchers can produce more informed and time-sensitive health policies, clinical practice guidelines, and regulatory submissions.

Related Story

Artificial Intelligence

 CA based Evidence Partners to Announce Growth Financing Round | Pharmtech Focus

CA based Evidence Partners to Announce Growth Financing Round

August 9 2022

Evidence Partners® Inc., the market leader in AI-enabled literature review automation software and creator of […]